AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Alto Neuroscience investors sue over alleged securities fraud in IPO.
ByAinvest
Friday, Sep 12, 2025 9:00 am ET1min read
Levi & Korsinsky has filed a class action lawsuit on behalf of Alto Neuroscience investors who purchased the company's stock between February 2, 2024, and October 22, 2024. The lawsuit alleges securities fraud and seeks to recover losses for affected investors. Those who purchased Alto common stock during this period may be eligible to participate in the lawsuit.
New York, NY / September 12, 2025 - Levi & Korsinsky has filed a class action lawsuit on behalf of investors who purchased Alto Neuroscience Inc. (NYSE: ANRO) stock between February 2, 2024, and October 22, 2024. The lawsuit alleges securities fraud and seeks to recover losses for affected investors.The complaint alleges that Alto Neuroscience made materially false and misleading statements concerning the clinical, regulatory, and commercial prospects of ALTO-100, a drug developed for the treatment of major depressive disorder. The lawsuit claims that the company overstated the effectiveness of ALTO-100, leading investors to believe that the drug was more effective than it actually was. As a result, the company's business and financial prospects were also overstated.
Investors who purchased Alto common stock during the specified period may be eligible to participate in the lawsuit. The deadline to request appointment as lead plaintiff is September 19, 2025. Those interested can visit the firm's website or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com [1].
Levi & Korsinsky, a well-known law firm specializing in securities fraud class actions, has a track record of recovering millions of dollars for investors. The firm has been recognized for its success in representing investors in complex litigation.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet